Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.

[1]  V. Felipo,et al.  Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications , 2019, Acta physiologica.

[2]  Guo-yi Gao,et al.  Traumatic brain injury in China , 2019, The Lancet Neurology.

[3]  S. S. Fatima,et al.  Evaluation of soluble TNF-like weak inducer of apoptosis (sTWEAK) levels to predict preeclampsia in early weeks of pregnancy. , 2019, European journal of obstetrics, gynecology, and reproductive biology.

[4]  J. Ranjeva,et al.  High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis , 2019, Journal of Translational Medicine.

[5]  A. Nagel,et al.  Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis , 2019, Front. Neurol..

[6]  K. Nash,et al.  Neuroinflammation and fractalkine signaling in Alzheimer’s disease , 2019, Journal of Neuroinflammation.

[7]  Seyed A Safavynia,et al.  The Role of Neuroinflammation in Postoperative Cognitive Dysfunction: Moving From Hypothesis to Treatment , 2019, Front. Psychiatry.

[8]  Jianwei Pan,et al.  Serum ST2 as a potential prognostic biomarker for traumatic brain injury. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[9]  C. Ryalino,et al.  Modified Revised Trauma–Marshall score as a proposed tool in predicting the outcome of moderate and severe traumatic brain injury , 2018, Open access emergency medicine : OAEM.

[10]  M. V. van Es,et al.  Outcome in Patients with Isolated Moderate to Severe Traumatic Brain Injury , 2018, Critical care research and practice.

[11]  M. Drutskaya,et al.  Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis , 2018, Biochemistry (Moscow).

[12]  Raghavendra Nayak,et al.  Serum Magnesium as a Marker of Neurological Outcome in Severe Traumatic Brain Injury Patients , 2018, Asian journal of neurosurgery.

[13]  M. Chopp,et al.  Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities , 2018, Chinese journal of traumatology = Zhonghua chuang shang za zhi.

[14]  T. V. van Essen,et al.  Decision making in very severe traumatic brain injury (Glasgow Coma Scale 3-5): a literature review of acute neurosurgical management. , 2018, Journal of neurosurgical sciences.

[15]  Shu-Yan Liu,et al.  Clinical significance of serum interleukin‐8 and soluble tumor necrosis factor‐like weak inducer of apoptosis levels in patients with diabetic nephropathy , 2018, Journal of diabetes investigation.

[16]  Hester F. Lingsma,et al.  Differential effects of the Glasgow Coma Scale Score and its Components: An analysis of 54,069 patients with traumatic brain injury. , 2017, Injury.

[17]  S. Acosta,et al.  Neuroinflammation in traumatic brain injury: A chronic response to an acute injury , 2017, Brain circulation.

[18]  Saurabh Sharma,et al.  Recent Advances in Pathophysiology of Traumatic Brain Injury , 2017, Current neuropharmacology.

[19]  N. Greig,et al.  Neuroinflammation in animal models of traumatic brain injury , 2016, Journal of Neuroscience Methods.

[20]  M. Schwartz,et al.  TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. , 2015, Journal of autoimmunity.

[21]  Dingbo Yang,et al.  Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury , 2014, Peptides.

[22]  J. Rysä,et al.  Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling , 2012, Annals of medicine.

[23]  M. Ren,et al.  The role of TWEAK/Fn14 in cardiac remodeling , 2012, Molecular Biology Reports.

[24]  Qiao-ling Zhou,et al.  Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis , 2012, Inflammation Research.

[25]  M. Sánchez-Niño,et al.  TWEAK, a multifunctional cytokine in kidney injury. , 2011, Kidney international.

[26]  C. Sommer,et al.  Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke , 2008, Journal of the Neurological Sciences.

[27]  M. Yepes.  TWEAK and the Central Nervous System , 2007, Molecular Neurobiology.

[28]  M. Yepes.  Tweak and FN14 in central nervous system health and disease. , 2007, Frontiers in bioscience : a journal and virtual library.

[29]  L. Burkly,et al.  TWEAK—Fn14 Pathway Inhibition Protects the Integrity of the Neurovascular Unit during Cerebral Ischemia , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  M. Yepes,et al.  Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases. , 2006, Drug news & perspectives.

[31]  M. Berens,et al.  TWEAK and Fn14: new molecular targets for cancer therapy? , 2006, Cancer letters.

[32]  M. T. Hasan,et al.  IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.

[33]  D. Lawrence,et al.  A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. , 2005, The American journal of pathology.

[34]  J. Winkles,et al.  TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. , 2003, Cytokine & growth factor reviews.

[35]  Dingbo Yang,et al.  Prognostic significance of serum translocator protein in patients with traumatic brain injury. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[36]  Ş. Arslan,et al.  Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease. , 2018, Acta medica.